RECRUITING

Determinants of Changes in Arterial Load Following Exercise

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to learn about how blood vessel dilation after exercise effects pulse wave reflection and influences the function of the heart in healthy young adults. The main question it aims to answer is: Are post-exercise decreases in reflected pulse waves due to a decrease in the stiffness of large arteries in the leg or an increase in leg blood flow? Participants will exercise on a stationary bicycle at a moderate intensity for 1 hour during two laboratory visits. Participants will take oral antihistamines to block post-exercise dilation at one visit, and they will take placebo pills at the other visit. At both visits, leg blood flow, pulse wave velocity, and heart function will be measured before exercise and for 120-minutes after exercise.

Official Title

Determinants of Changes in Arterial Load Following Exercise

Quick Facts

Study Start:2023-05-12
Study Completion:2024-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05820243

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * healthy men and women
  2. * sedentary or recreationally active
  1. * history of cardiovascular events or procedures
  2. * stage 2 hypertension (BP: ≥140 systolic or ≥90 diastolic)
  3. * metabolic syndrome
  4. * renal disease
  5. * chronic respiratory disease
  6. * currently prescribed any cardiovascular medication
  7. * current use of erythromycin and/ ketoconazole
  8. * current pregnancy or breastfeeding -hormone replacement therapy-
  9. * tobacco use
  10. * musculoskeletal injury/disorder that would inhibit cycling exercise
  11. * body mass index (BMI) \<18.5 or \>35kg/m\^2
  12. * reduced kidney function (estimated glomerular filtration rate\< 90ml/min/1.73 m\^2)
  13. * daily use of fexofenadine and/or famotidine

Contacts and Locations

Study Contact

David Edwards, PhD
CONTACT
302-831-3363
dge@udel.edu
Jordan Patik, PhD
CONTACT
5128206387
jpatik@udel.edu

Study Locations (Sites)

Department of Kinesiology and Applied Physiology, University of Delaware
Newark, Delaware, 19713
United States

Collaborators and Investigators

Sponsor: University of Delaware

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-12
Study Completion Date2024-09

Study Record Updates

Study Start Date2023-05-12
Study Completion Date2024-09

Terms related to this study

Keywords Provided by Researchers

  • arterial stiffness
  • wave reflections
  • pulsatile load

Additional Relevant MeSH Terms

  • Post-Exercise Hypotension